Tirzepatide
Appetite regulation, weight management, glycaemic control and metabolic health support.
Certificate of Analysis
Contact the research team for current batch information.
Research context
⚖️ Tirzepatide
Weight Management • Appetite Control • Metabolic Health
Tirzepatide is a dual GIP and GLP-1 receptor agonist used for chronic weight management and type 2 diabetes under appropriate medical supervision. It works by improving appetite regulation, increasing satiety and supporting glucose control.
Key Benefits
Reduces appetite & food intake
Promotes weight and body-fat reduction
Improves blood glucose control
Supports insulin sensitivity
Slows gastric emptying and increases satiety
Can improve several cardiometabolic risk factors
Common Side Effects
Nausea, diarrhoea, constipation, vomiting, abdominal discomfort and reduced appetite are most common, particularly during dose escalation.
Administration: Subcutaneous injection, typically once weekly
Storage: Refrigerated at 2–8°C
Note: Tirzepatide dosing should be gradually titrated according to tolerability and clinician guidance. Avoid rapid dose increases simply to accelerate weight loss.
Tirzepatide poster
